ProtoQSAR

ProtoQSAR appears to be a health-related company focused on computational chemistry, QSAR modeling, and in silico methods to support drug discovery and safety assessment. The company is associated with predictive modeling services and software capabilities used to evaluate chemical structures, ADME, and toxicology risk rather than advancing a disclosed proprietary therapeutic pipeline. Based on the available context, ProtoQSAR looks more like a platform and services business serving pharma, biotech, chemicals, and related R&D users than a traditional therapeutic developer. Public evidence of clinical-stage assets, approved products, or a broad internal drug pipeline is limited.